Clinical Trials
3 trialsNCT05154396 2021-12-13
Neratinib Dose Escalation Regimen for HER2 Positive Early Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT03933319 2020-07-08
Phase Ⅱ Study of Pegylated Liposomal Doxorubicin（PLD）Plus Trastuzumab in HER-2 Positive Metastatic Breast Cancer
ChineseAMS
Phase 2 Unknown
NCT04158505 2020-04-24
Real World Study of Pyrotinib in Human Epidermal Growth Factor Receptor-2 (HER2) Positive Breast Cancer
ChineseAMS
Unknown